Ablation Devices Market Report and Forecast 2025-2034
Description
The global ablation devices market was valued at USD 6.13 Billion in 2024, driven by the increasing technological advancements across the globe. The market is anticipated to grow at a CAGR of 9.50% during the forecast period of 2025-2034, with the values likely to reach USD 15.19 Billion by 2034.
Ablation Devices Market Overview
Ablation devices are used to precisely remove or destroy abnormal tissue in the body, typically through minimally invasive procedures. The primary purpose is to treat conditions such as arrhythmias (irregular heartbeats), cancerous or benign tumors, chronic pain, and certain gynecological disorders. Ablation devices work by using energy sources such as radiofrequency, microwave, laser, or cryoablation to target and eliminate the problematic tissue without affecting surrounding healthy tissue. This approach can reduce the need for open surgery, lessen recovery time, and lower risks for patients by providing a targeted, controlled treatment option.
Ablation Devices Market Growth Drivers
FDA Approval of Johnson & Johnson's Varipulse System Drives Market Expansion
The rising prevalence of atrial fibrillation (AF) and the need for advanced, minimally invasive treatments are key drivers of the market. In November 2024, Johnson & Johnson MedTech received FDA approval for its Varipulse pulsed-field ablation (PFA) system, specifically for treating drug-resistant paroxysmal AF. The Varipulse system, integrated with Johnson & Johnson's Carto 3 electroanatomical mapping system, enables real-time procedural guidance and lesion tracking, enhancing procedural accuracy. This FDA approval, supported by positive results from the admIRE trial, reflects significant advancements in AF treatment technology. The Varipulse system is poised to impact market growth by offering a targeted, efficient solution for AF, likely accelerating the adoption of PFA systems during the forecast period.
Rising Innovations to Meet Rising Ablation Devices Market Demand
The increasing demand for efficient post-operative pain management and advancements in cryotherapy are key drivers for the global ablation devices market. In October 2024, AtriCure, Inc., launched its cryoSPHERE MAX cryoablation probe, a next-generation device designed to optimise Cryo Nerve Block therapy (cryoNB) for managing post-operative pain. This new probe features an enlarged ball tip, reducing freeze times by 50% compared to its predecessor, the cryoSPHERE cryoablation probe, and by over 30% compared to the cryoSPHERE®+ probe. AtriCure’s innovation in cryoablation technology addresses the need for faster, more efficient procedures, which is expected to drive market growth by expanding the clinical applications of cryoablation during the forecast period.
Ablation Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Technological Innovations Propel Ablation Devices Market Growth
The market is experiencing swift technological advancements, notably in pulsed-field and laser ablation systems that improve precision and safety. In October 2024, Abbott announced significant progress in expanding its pulsed field ablation (PFA) solutions in electrophysiology. Key milestones included the early completion of enrolment for the VOLT-AF IDE Study, supporting the Volt PFA System, and the launch of the FOCALFLEX trial, designed to assess the TactiFlex Duo Ablation Catheter, Sensor Enabled (SE), for treating paroxysmal atrial fibrillation. These innovations address the growing demand for minimally invasive procedures, driving market growth by offering effective alternatives for complex cardiovascular and oncology treatments, with a dedicated emphasis on improving patient recovery and outcomes.
Rising FDA Approvals Fuel Market Expansion and Adoption
Rising FDA approvals for novel ablation technologies are driving significant market growth. In October 2024, Boston Scientific received FDA approval for its navigation-enabled ablation catheter for paroxysmal atrial fibrillation, along with 510(k) clearance for new imaging software for its pulsed-field ablation system. Following these approvals, the company immediately launched the ablation catheter (Farawave Nav) and imaging software (Faraview) commercially. These regulatory endorsements validate device safety and efficacy, allowing faster integration into healthcare settings. FDA support builds trust among providers and patients, accelerating the adoption and market reach of advanced ablation devices.
Market Shift Toward Minimally Invasive Treatments Drives Value
The growing shift toward minimally invasive procedures in healthcare is significantly boosting demand for ablation devices. These techniques, which offer faster recovery times, reduced complication risks, and cost savings, are highly appealing to both patients and providers. In July 2024, Stryker launched the MultiGen 2 Radiofrequency (RF) Generator, a cutting-edge device that enhances efficiency, control, and reliability for RF ablation procedures, offering lasting relief for those with facet joint pain. This trend is poised to increase market value, especially as advanced ablation solutions become increasingly available across various healthcare settings.
Emerging Markets Contribute Significantly to Global Market Development
Asia-Pacific and Latin America markets are becoming key contributors to global ablation device sales due to expanding healthcare infrastructure and increasing access to advanced technologies. With rising healthcare expenditure and a higher prevalence of treatable diseases, these regions present substantial growth opportunities, further driving global market development and enabling better patient outcomes.
Ablation Devices Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
Market Share Based on Technology to Witness Significant Growth
On the basis of technology, radiofrequency devices, ultrasound devices, laser ablation, cryoablation devices and others. Radiofrequency devices hold the largest market share in the market. This dominance is due to their versatility, precision, and effectiveness across various applications, including cardiology and oncology, where precise tissue targeting is essential.
Ablation Devices Market Analysis by Region
North America holds the largest market share in the market, driven by its strong focus on adopting innovative medical technologies, especially in cardiac and oncology treatments. The region’s advanced healthcare systems and significant investment in clinical trials allow for quicker adoption of cutting-edge ablation technologies, such as pulsed-field ablation and radiofrequency devices. Furthermore, North America’s proactive regulatory environment, which includes numerous FDA approvals for advanced ablation solutions, accelerates market growth by enabling faster commercialisation. This combination of technological leadership and robust regulatory support positions North America as the leading region in the ablation devices market.
Leading Players in the Ablation Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc
Headquartered in Dublin, Ireland, and established in 1949, Medtronic plc is a global leader in medical technology. In the ablation devices market, Medtronic offers a comprehensive range of products, including radiofrequency and cryoablation systems, designed to treat various conditions such as cardiac arrhythmias and chronic pain. Their portfolio features advanced technologies like the Arctic Front Advance Cryoballoon and the PulseSelect Pulsed Field Ablation System, which provide minimally invasive solutions for precise tissue ablation.
Johnson & Johnson
Founded in 1886 and headquartered in New Brunswick, New Jersey, USA, Johnson & Johnson operates through its subsidiary, Biosense Webster in the market. They specialize in electrophysiology products, offering innovative ablation technologies such as the Varipulse Pulsed Field Ablation System, which received FDA approval in November 2024 for treating atrial fibrillation. Their portfolio includes advanced catheters and mapping systems aimed at improving patient outcomes in cardiac care.
Abbott Laboratories
Established in 1888 and based in Abbott Park, Illinois, USA, Abbott Laboratories provides a range of ablation devices through its electrophysiology division. Their portfolio includes radiofrequency ablation systems and catheters designed for the treatment of cardiac arrhythmias. Abbott focuses on developing technologies that enhance the precision and safety of ablation procedures, contributing to improved patient care in the cardiovascular field.
Boston Scientific Corporation
Headquartered in Marlborough, Massachusetts, USA, and founded in 1979, Boston Scientific Corporation offers a diverse range of ablation devices. Their portfolio includes the FARAPULSE Pulsed Field Ablation System, which has shown significant growth in electrophysiology sales. Boston Scientific's ablation technologies are designed to provide minimally invasive solutions for treating various cardiac conditions, enhancing procedural efficiency and patient outcomes.
Other key players in the market include AngioDynamics Inc., Smith & Nephew plc, Stryker Corporation, Hologic, Inc., CONMED Corporation, and Olympus Corporation.
Key Questions Answered in the Ablation Devices Market
Ablation Devices Market Overview
Ablation devices are used to precisely remove or destroy abnormal tissue in the body, typically through minimally invasive procedures. The primary purpose is to treat conditions such as arrhythmias (irregular heartbeats), cancerous or benign tumors, chronic pain, and certain gynecological disorders. Ablation devices work by using energy sources such as radiofrequency, microwave, laser, or cryoablation to target and eliminate the problematic tissue without affecting surrounding healthy tissue. This approach can reduce the need for open surgery, lessen recovery time, and lower risks for patients by providing a targeted, controlled treatment option.
Ablation Devices Market Growth Drivers
FDA Approval of Johnson & Johnson's Varipulse System Drives Market Expansion
The rising prevalence of atrial fibrillation (AF) and the need for advanced, minimally invasive treatments are key drivers of the market. In November 2024, Johnson & Johnson MedTech received FDA approval for its Varipulse pulsed-field ablation (PFA) system, specifically for treating drug-resistant paroxysmal AF. The Varipulse system, integrated with Johnson & Johnson's Carto 3 electroanatomical mapping system, enables real-time procedural guidance and lesion tracking, enhancing procedural accuracy. This FDA approval, supported by positive results from the admIRE trial, reflects significant advancements in AF treatment technology. The Varipulse system is poised to impact market growth by offering a targeted, efficient solution for AF, likely accelerating the adoption of PFA systems during the forecast period.
Rising Innovations to Meet Rising Ablation Devices Market Demand
The increasing demand for efficient post-operative pain management and advancements in cryotherapy are key drivers for the global ablation devices market. In October 2024, AtriCure, Inc., launched its cryoSPHERE MAX cryoablation probe, a next-generation device designed to optimise Cryo Nerve Block therapy (cryoNB) for managing post-operative pain. This new probe features an enlarged ball tip, reducing freeze times by 50% compared to its predecessor, the cryoSPHERE cryoablation probe, and by over 30% compared to the cryoSPHERE®+ probe. AtriCure’s innovation in cryoablation technology addresses the need for faster, more efficient procedures, which is expected to drive market growth by expanding the clinical applications of cryoablation during the forecast period.
Ablation Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Technological Innovations Propel Ablation Devices Market Growth
The market is experiencing swift technological advancements, notably in pulsed-field and laser ablation systems that improve precision and safety. In October 2024, Abbott announced significant progress in expanding its pulsed field ablation (PFA) solutions in electrophysiology. Key milestones included the early completion of enrolment for the VOLT-AF IDE Study, supporting the Volt PFA System, and the launch of the FOCALFLEX trial, designed to assess the TactiFlex Duo Ablation Catheter, Sensor Enabled (SE), for treating paroxysmal atrial fibrillation. These innovations address the growing demand for minimally invasive procedures, driving market growth by offering effective alternatives for complex cardiovascular and oncology treatments, with a dedicated emphasis on improving patient recovery and outcomes.
Rising FDA Approvals Fuel Market Expansion and Adoption
Rising FDA approvals for novel ablation technologies are driving significant market growth. In October 2024, Boston Scientific received FDA approval for its navigation-enabled ablation catheter for paroxysmal atrial fibrillation, along with 510(k) clearance for new imaging software for its pulsed-field ablation system. Following these approvals, the company immediately launched the ablation catheter (Farawave Nav) and imaging software (Faraview) commercially. These regulatory endorsements validate device safety and efficacy, allowing faster integration into healthcare settings. FDA support builds trust among providers and patients, accelerating the adoption and market reach of advanced ablation devices.
Market Shift Toward Minimally Invasive Treatments Drives Value
The growing shift toward minimally invasive procedures in healthcare is significantly boosting demand for ablation devices. These techniques, which offer faster recovery times, reduced complication risks, and cost savings, are highly appealing to both patients and providers. In July 2024, Stryker launched the MultiGen 2 Radiofrequency (RF) Generator, a cutting-edge device that enhances efficiency, control, and reliability for RF ablation procedures, offering lasting relief for those with facet joint pain. This trend is poised to increase market value, especially as advanced ablation solutions become increasingly available across various healthcare settings.
Emerging Markets Contribute Significantly to Global Market Development
Asia-Pacific and Latin America markets are becoming key contributors to global ablation device sales due to expanding healthcare infrastructure and increasing access to advanced technologies. With rising healthcare expenditure and a higher prevalence of treatable diseases, these regions present substantial growth opportunities, further driving global market development and enabling better patient outcomes.
Ablation Devices Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
- Radiofrequency Devices
- Ultrasound Devices
- Laser Ablation
- Cryoablation Devices
- Other
- Ophthalmology
- Gynecology
- Urology
- Cosmetic Surgery
- Oncology
- Cardiology
- Others
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Share Based on Technology to Witness Significant Growth
On the basis of technology, radiofrequency devices, ultrasound devices, laser ablation, cryoablation devices and others. Radiofrequency devices hold the largest market share in the market. This dominance is due to their versatility, precision, and effectiveness across various applications, including cardiology and oncology, where precise tissue targeting is essential.
Ablation Devices Market Analysis by Region
North America holds the largest market share in the market, driven by its strong focus on adopting innovative medical technologies, especially in cardiac and oncology treatments. The region’s advanced healthcare systems and significant investment in clinical trials allow for quicker adoption of cutting-edge ablation technologies, such as pulsed-field ablation and radiofrequency devices. Furthermore, North America’s proactive regulatory environment, which includes numerous FDA approvals for advanced ablation solutions, accelerates market growth by enabling faster commercialisation. This combination of technological leadership and robust regulatory support positions North America as the leading region in the ablation devices market.
Leading Players in the Ablation Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc
Headquartered in Dublin, Ireland, and established in 1949, Medtronic plc is a global leader in medical technology. In the ablation devices market, Medtronic offers a comprehensive range of products, including radiofrequency and cryoablation systems, designed to treat various conditions such as cardiac arrhythmias and chronic pain. Their portfolio features advanced technologies like the Arctic Front Advance Cryoballoon and the PulseSelect Pulsed Field Ablation System, which provide minimally invasive solutions for precise tissue ablation.
Johnson & Johnson
Founded in 1886 and headquartered in New Brunswick, New Jersey, USA, Johnson & Johnson operates through its subsidiary, Biosense Webster in the market. They specialize in electrophysiology products, offering innovative ablation technologies such as the Varipulse Pulsed Field Ablation System, which received FDA approval in November 2024 for treating atrial fibrillation. Their portfolio includes advanced catheters and mapping systems aimed at improving patient outcomes in cardiac care.
Abbott Laboratories
Established in 1888 and based in Abbott Park, Illinois, USA, Abbott Laboratories provides a range of ablation devices through its electrophysiology division. Their portfolio includes radiofrequency ablation systems and catheters designed for the treatment of cardiac arrhythmias. Abbott focuses on developing technologies that enhance the precision and safety of ablation procedures, contributing to improved patient care in the cardiovascular field.
Boston Scientific Corporation
Headquartered in Marlborough, Massachusetts, USA, and founded in 1979, Boston Scientific Corporation offers a diverse range of ablation devices. Their portfolio includes the FARAPULSE Pulsed Field Ablation System, which has shown significant growth in electrophysiology sales. Boston Scientific's ablation technologies are designed to provide minimally invasive solutions for treating various cardiac conditions, enhancing procedural efficiency and patient outcomes.
Other key players in the market include AngioDynamics Inc., Smith & Nephew plc, Stryker Corporation, Hologic, Inc., CONMED Corporation, and Olympus Corporation.
Key Questions Answered in the Ablation Devices Market
- What was the global ablation devices market value in 2024?
- What is the ablation devices market forecast outlook for 2025-2034?
- What is the market breakup based on the technology?
- What is the market breakup based on application?
- What is the market breakup based on the end user?
- What are the major factors aiding the ablation devices market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major ablation devices market trends?
- Which technology will lead the market segment?
- Which application will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the ablation devices market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Ablation Devices Market Overview
- 3.1 Global Ablation Devices Market Historical Value (2018-2024)
- 3.2 Global Ablation Devices Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Ablation Devices Market Landscape*
- 5.1 Global Ablation Devices Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Ablation Devices Market: Product Landscape
- 5.2.1 Analysis by Technology
- 5.2.2 Analysis by Application
- 6 Global Ablation Devices Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Ablation Devices Market Segmentation (218-2034)
- 7.1 Global Ablation Devices Market (2018-2034) by Technology
- 7.1.1 Market Overview
- 7.1.2 Radiofrequency Devices
- 7.1.3 Ultrasound Devices
- 7.1.4 Laser Ablation
- 7.1.5 Cryoablation Devices
- 7.1.6 Others
- 7.2 Global Ablation Devices Market (2018-2034) by Application
- 7.2.1 Market Overview
- 7.2.2 Ophthalmology
- 7.2.3 Gynecology
- 7.2.4 Urology
- 7.2.5 Cosmetic Surgery
- 7.2.6 Oncology
- 7.2.7 Cardiology
- 7.2.8 Others
- 7.3 Global Ablation Devices Market (2018-2034) by End User
- 7.3.1 Market Overview
- 7.3.2 Hospitals
- 7.3.3 Ambulatory Surgical Centers
- 7.3.4 Clinics
- 7.3.5 Others
- 7.4 Global Ablation Devices Market (2018-2034) by Region
- 7.4.1 Market Overview
- 7.4.2 North America
- 7.4.3 Europe
- 7.4.4 Asia Pacific
- 7.4.5 Latin America
- 7.4.6 Middle East and Africa
- 8 North America Ablation Devices Market (218-2034)
- 8.1 North America Ablation Devices Market (2018-2034) by Technology
- 8.1.1 Market Overview
- 8.1.2 Radiofrequency Devices
- 8.1.3 Ultrasound Devices
- 8.1.4 Laser Ablation
- 8.1.5 Cryoablation Devices
- 8.1.6 Others
- 8.2 North America Ablation Devices Market (2018-2034) by Application
- 8.2.1 Market Overview
- 8.2.2 Ophthalmology
- 8.2.3 Gynecology
- 8.2.4 Urology
- 8.2.5 Cosmetic Surgery
- 8.2.6 Oncology
- 8.2.7 Cardiology
- 8.2.8 Others
- 8.3 North America Ablation Devices Market (2018-2034) by End User
- 8.3.1 Market Overview
- 8.3.2 Hospitals
- 8.3.3 Ambulatory Surgical Centers
- 8.3.4 Clinics
- 8.3.5 Others
- 8.4 North America Ablation Devices Market (2018-2034) by Country
- 8.4.1 United States of America
- 8.4.2 Canada
- 9 Europe Ablation Devices Market (218-2034)
- 9.1 Europe Ablation Devices Market (2018-2034) by Technology
- 9.1.1 Market Overview
- 9.1.2 Radiofrequency Devices
- 9.1.3 Ultrasound Devices
- 9.1.4 Laser Ablation
- 9.1.5 Cryoablation Devices
- 9.1.6 Others
- 9.2 Europe Ablation Devices Market (2018-2034) by Application
- 9.2.1 Market Overview
- 9.2.2 Ophthalmology
- 9.2.3 Gynecology
- 9.2.4 Urology
- 9.2.5 Cosmetic Surgery
- 9.2.6 Oncology
- 9.2.7 Cardiology
- 9.2.8 Others
- 9.3 Europe Ablation Devices Market (2018-2034) by End User
- 9.3.1 Market Overview
- 9.3.2 Hospitals
- 9.3.3 Ambulatory Surgical Centers
- 9.3.4 Clinics
- 9.3.5 Others
- 9.4 Europe Ablation Devices Market (2018-2034) by Country
- 9.4.1 United Kingdom
- 9.4.2 Germany
- 9.4.3 France
- 9.4.4 Italy
- 9.4.5 Others
- 10 Asia Pacific Ablation Devices Market (218-2034)
- 10.1 Asia Pacific Ablation Devices Market (2018-2034) by Technology
- 10.1.1 Market Overview
- 10.1.2 Radiofrequency Devices
- 10.1.3 Ultrasound Devices
- 10.1.4 Laser Ablation
- 10.1.5 Cryoablation Devices
- 10.1.6 Others
- 10.2 Asia Pacific Ablation Devices Market (2018-2034) by Application
- 10.2.1 Market Overview
- 10.2.2 Ophthalmology
- 10.2.3 Gynecology
- 10.2.4 Urology
- 10.2.5 Cosmetic Surgery
- 10.2.6 Oncology
- 10.2.7 Cardiology
- 10.2.8 Others
- 10.3 Asia Pacific Ablation Devices Market (2018-2034) by End User
- 10.3.1 Market Overview
- 10.3.2 Hospitals
- 10.3.3 Ambulatory Surgical Centers
- 10.3.4 Clinics
- 10.3.5 Others
- 10.4 Asia Pacific Ablation Devices Market (2018-2034) by Country
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 ASEAN
- 10.4.5 Australia
- 10.4.6 Others
- 11 Latin America Ablation Devices Market (218-2034)
- 11.1 Latin America Ablation Devices Market (2018-2034) by Technology
- 11.1.1 Market Overview
- 11.1.2 Radiofrequency Devices
- 11.1.3 Ultrasound Devices
- 11.1.4 Laser Ablation
- 11.1.5 Cryoablation Devices
- 11.1.6 Others
- 11.2 Latin America Ablation Devices Market (2018-2034) by Application
- 11.2.1 Market Overview
- 11.2.2 Ophthalmology
- 11.2.3 Gynecology
- 11.2.4 Urology
- 11.2.5 Cosmetic Surgery
- 11.2.6 Oncology
- 11.2.7 Cardiology
- 11.2.8 Others
- 11.3 Latin America Ablation Devices Market (2018-2034) by End User
- 11.3.1 Market Overview
- 11.3.2 Hospitals
- 11.3.3 Ambulatory Surgical Centers
- 11.3.4 Clinics
- 11.3.5 Others
- 11.4 Latin America Ablation Devices Market (2018-2034) by Country
- 11.4.1 Brazil
- 11.4.2 Argentina
- 11.4.3 Mexico
- 11.4.4 Others
- 12 Middle East and Africa Ablation Devices Market (218-2034)
- 12.1 Middle East and Africa Ablation Devices Market (2018-2034) by Technology
- 12.1.1 Market Overview
- 12.1.2 Radiofrequency Devices
- 12.1.3 Ultrasound Devices
- 12.1.4 Laser Ablation
- 12.1.5 Cryoablation Devices
- 12.1.6 Others
- 12.2 Middle East and Africa Ablation Devices Market (2018-2034) by Application
- 12.2.1 Market Overview
- 12.2.2 Ophthalmology
- 12.2.3 Gynecology
- 12.2.4 Urology
- 12.2.5 Cosmetic Surgery
- 12.2.6 Oncology
- 12.2.7 Cardiology
- 12.2.8 Others
- 12.3 Middle East and Africa Ablation Devices Market (2018-2034) by End User
- 12.3.1 Market Overview
- 12.3.2 Hospitals
- 12.3.3 Ambulatory Surgical Centers
- 12.3.4 Clinics
- 12.3.5 Others
- 12.4 Middle East and Africa Ablation Devices Market (2018-2034) by Country
- 12.4.1 Saudi Arabia
- 12.4.2 United Arab Emirates
- 12.4.3 Nigeria
- 12.4.4 South Africa
- 12.4.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Drug Class of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Drug Class of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share Analysis, By Region (Top 5 Companies)
- 17.1.1 Market Share Analysis: Global
- 17.1.2 Market Share Analysis: North America
- 17.1.3 Market Share Analysis: Europe
- 17.1.4 Market Share Analysis: Asia Pacific
- 17.1.5 Market Share Analysis: Others
- 17.2 Medtronic plc
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Company News and Development
- 17.2.5 Certifications
- 17.3 Johnson & Johnson
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Company News and Development
- 17.3.5 Certifications
- 17.4 Abbott Laboratories
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Company News and Development
- 17.4.5 Certifications
- 17.5 Boston Scientific Corporation
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Company News and Development
- 17.5.5 Certifications
- 17.6 AngioDynamics Inc.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Company News and Development
- 17.6.5 Certifications
- 17.7 Smith & Nephew plc
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Company News and Development
- 17.7.5 Certifications
- 17.8 Stryker Corporation
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Company News and Development
- 17.8.5 Certifications
- 17.9 Hologic, Inc.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Company News and Development
- 17.9.5 Certifications
- 17.10 CONMED Corporation
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Company News and Development
- 17.10.5 Certifications
- 17.11 Olympus Corporation
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Company News and Development
- 17.11.5 Certifications
- 18 Global Ablation Devices Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
